Michelle Lazenby

Prognostic Significance of <i>NPM1</i> Mutations in the Absence of <i>FLT3</i> –Internal Tandem Duplication in Older Patients With Acute Myeloid Leukemia: A SWOG and UK National Cancer Research Institute/Medical Research Council Report

Fabiana Ostronoff, Megan Othus, Michelle Lazenby et al. · Journal of Clinical Oncology · 2015 · 131 citations · Full text

The prognostic relevance of flt3 and npm1 mutations on older patients treated intensively or non-intensively: a study of 1312 patients in the UK NCRI AML16 trial

Michelle Lazenby, Amanda Gilkes, Ceri Marrin et al. · Leukemia · 2014 · 59 citations

Disease Progression, Medicine, Prognostic Relevance +8

Synthesis and preliminary evaluation of poly(amidoamine)–melittin conjugates as endosomolytic polymers and/or potential anticancer therapeutics

Nathalie Lavignac, Michelle Lazenby, Jacopo Franchini et al. · International Journal of Pharmaceutics · 2005 · 51 citations · Full text

Nanomedicine, Medicinal Chemistry, Endosomolytic Polymers +14

The cyclin-dependent kinase inhibitor SNS-032 has single agent activity in AML cells and is highly synergistic with cytarabine

Elisabeth Walsby, Michelle Lazenby, Chris Pepper et al. · Leukemia · 2011 · 51 citations

Single Agent Activity, Signal Transduction, Medicine +9

Synthesis and Endosomolytic Properties of Poly(amidoamine) Block Copolymers

Nathalie Lavignac, Michelle Lazenby, Beatrice Malgesini et al. · Macromolecular Bioscience · 2004 · 37 citations

Isa 1, Paa Biological Characteristics, Block Co-polymers +15